Reducing blood loss following vaginal delivery
Conditions
Interventions
placebo group
Sponsors
NAFISA MUHAMMAD IBRAHIM
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Women with singleton pregnancy at term Presenting in spontaneous labour no contraindication to vaginal delivery women who have consented to the study
Exclusion criteria
Exclusion criteria: Hypersensitivity to oxytocin or tranexamic acid women with known history of thrombotic events (including thrombophilia and coagulopathy), cardiac diseases, renal or liver diseases, epilepsy Any contraindications to vaginal delivery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare the effect of prophylactic administration of combined tranexamic acid/oxytocin at reducing blood loss during vaginal delivery and to evaluate the effect of prophylactic administration of oxytocin alone at reducing blood loss during vaginal delivery in Maitama District Hospital, Abuja.istrict Hospital, Abuja. | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine and compare the incidence of primary PPH, need for additional uterotonics, blood transfusion and occurrence of maternal side effects and need for surgical intervention among parturients receiving prophylactic combined tranexamic acid/oxytocin and those receiving oxytocin alone for reducing blood loss during vaginal delivery in MDH Abuja. | — |
Countries
Nigeria
Contacts
Public ContactJAMEELA KHADEEJA SODANGI
SENIOR REGISTRAR
Outcome results
None listed